In the current study, we investigated the expression of 11ßHSD2 in lung cancers and whether inhibition of 11ßHSD2 activity could suppress lung tumorigenesis due to increased tumor cell intracellular active glucocorticoids and subsequent inhibition of COX-2 expression/activity. Here, PTGS2 is linked to lung cancer.